fda warning letters glp-1 september 2025 news Last month, the issued 25 to telehealth companies over what it called false or misleading claims about compounded medications. Read more at the link in the comments below Congress Introduces SAFE Drugs Act

2 8 12 But those data are confounded by co-administration with semaglutide, so the cagrilintide-specific contribution cannot be cleanly isolated

Many physicians believe that GLP-1R agonists are underutilized and should be expanded to populations without diabetes or obesity

Can carotid bulb plaque assessment rule out significant coronary artery disease

doi: 10.3389/fnut.2025.1541054 Received 06 December 2024 Accepted 20 March 2025 Published 09 April 2025 Volume 12 - 2025 Edited by Peng An, China Agricultural University, China Reviewed by Naseem Akhtar Qureshi, Al-Falah University, India Denis Fedorinov, Russian Medical Academy of Postgraduate Education, Russia Updates Copyright 2025 Overton, Emelyanova and Bunik

Matrix metalloproteinases in emphysema